Abstract:Amyloids are insoluble fibrillar protein aggregates. While they are commonly found in human diseases, it is becoming increasingly clear that this type of structure is essential for a range of biological functions, with prominent examples in organisms ranging from bacteria to human. Functional amyloid and pathogenic amyloid share similar physical and chemical properties. Unlike pathological amyloids, however, the structures of functional amyloids are formed by polypeptide sequences whose amyloid structure has been under a positive evolutionary selection pressure. This important distinction provides us with an opportunity to obtain structural insights from an unexpected source: the covariation of amino acids among sequences within the same family of a functional amyloid protein. There is a long history for the idea of using coevolution for molecular structure prediction, but recent growth in sequence databases and new, efficient algorithms to disentangle indirect couplings in a network, have dramatically improved our ability to predict residue-residue contacts. We used recently developed sequence analysis methods (EVcoupling, PSICOV and GREMLIN) to extract distance restraints from a multiple sequence alignment of a functional amyloid protein. Together with an efficient force field, these restraints allow us to determine atomic resolution structural models. We find that the protein forms a beta-helical structure, where each turn corresponds to previously identified repeat sequences. The proposed structure is validated by previously published solid-state NMR, electron microscopy and X-ray diffraction data, and confirms an earlier proposed model derived by complementary means. To our knowledge, this is the first time the analysis of correlated mutations and computer simulations have been used together to study the structure of a functional amyloid. The current study therefore serves as a probe into the potential applicability of the approach in this domain.

Structure of cytotoxic amyloid oligomers generated during disaggregation

Molecular Simulations of Amyloid Structures, Toxicity, and Inhibition

Atomic View of a Toxic Amyloid Small Oligomer

Misfolded protein oligomers: mechanisms of formation, cytotoxic effects, and pharmacological approaches against protein misfolding diseases

Toxic fibrillar oligomers of amyloid-β have cross-β structure

Amyloid fibril cytotoxicity and associated disorders

Binding with nucleic acids or glycosaminoglycans converts soluble protein oligomers to amyloid.

Formation of Lamellar Micelle-Like Oligomers and Membrane Disruption Revealed by the Study of Short Peptide Hiapp18-27.

Annular oligomeric amyloid intermediates observed by in situ atomic force microscopy.

Molecular Mechanism of the Early Stage of Amyloidogenic Hexapeptides (NFGAIL) Aggregation

Aggregation mechanisms and molecular structures of amyloid‐β in Alzheimer's disease

Computational studies of protein aggregation mediated by amyloid: Fibril elongation and secondary nucleation

Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer's Disease, Parkinson's Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis.

What Does Evolution Tell Us About The Structure Of A Functional Amyloid Protein?

Soluble protein oligomers as emerging toxins in alzheimer's and other amyloid diseases

Gel Formation in Protein Amyloid Aggregation: A Physical Mechanism for Cytotoxicity

The Relationship Between Amyloid Structure and Cytotoxicity.

Exploring the Early Steps of Aggregation of Amyloid-Forming Peptide Kffe

pH-induced molecular shedding drives the formation of amyloid fibril-derived oligomers

Structural Diversity of Dimers of the Alzheimer Amyloid-Beta(25-35) Peptide and Polymorphism of the Resulting Fibrils.

Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer’s Disease, Parkinson’s Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis